Successful Primary Medical Therapy with Somatostatin Receptor Ligand in Acromegaly with Thyroid Cancer
Acromegaly is a rare disease with an annual incidence of 3 to 4 cases in a million.[1] Diagnosis is often delayed due to the slow progression of the disease. Persistent elevation of growth hormone (GH) in acromegaly causes a reduction in life expectancy by 10 years. Aside from multiple cardiovascula...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
ASEAN Federation of Endocrine Societies
2017-10-01
|
| Series: | Journal of the ASEAN Federation of Endocrine Societies |
| Subjects: | |
| Online Access: | https://asean-endocrinejournal.org/index.php/JAFES/article/view/395 |